🇺🇸 FDA
Patent

US 8409858

Modular functional peptides for the intracellular delivery of nanoparticles

granted A61KA61K47/6921A61K49/0093

Quick answer

US patent 8409858 (Modular functional peptides for the intracellular delivery of nanoparticles) held by United States of America as represented by the Secretary of the Air Force expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Apr 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K47/6921, A61K49/0093